01725oam 2200433 450 991071351490332120220415113959.030-195(CKB)5470000002502518(OCoLC)1156626520(OCoLC)995470000002502518(EXLCZ)99547000000250251820200603d2020 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierExamining oversight reports on the 340B Drug Pricing Program hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018Washington :U.S. Government Publishing Office,2020.1 online resource (iii, 46 pages)S. hrg. ;115-240Access ID (govinfo): CHRG-115shrg30195.Includes bibliographical references.Examining oversight reports on the 340B Drug Pricing Program Drug accessibilityGovernment policyUnited StatesDrugsPricesGovernment policyUnited StatesPrescription pricingGovernment policyUnited StatesLegislative hearings.lcgftDrug accessibilityGovernment policyDrugsPricesGovernment policyPrescription pricingGovernment policyGPOGPOGPOBOOK9910713514903321Examining oversight reports on the 340B Drug Pricing Program3549034UNINA